FDA's Center for Biologics Evaluation and Research regulates the following products: allergenic extracts, monoclonal antibodies, biotech derived therapeutics, somatic cell and gene therapy, xenotransplantation, tissues, some devices, whole blood, blood components, blood derivatives, and vaccines.
New Format Highlights 2017 ISPE/FDA/PQRI Quality Manufacturing Conference
Wednesday, 22 Mar 2017 16.03
Looking Ahead – 2017 Pharmaceutical Industry Trends
Monday, 20 Mar 2017 18.03
Reading Roundup: Top Blog Posts from February 2017
Friday, 17 Mar 2017 12.03